Evaluating the Use of Predictive Models in Combination with In Vitro Assays

11 Apr Evaluating the Use of Predictive Models in Combination with In Vitro Assays

IIVS is excited to announce the publication of 2 papers evaluating the use of predictive models in combination with in vitro assays to provide a quantitative assessment of skin sensitization potential. This work is presented Drs. Frank Gerberick (GF3 Consultancy, Chief Scientific Advisor to IIVS) and Andreas Natsch (Senior Research Fellow at Givaudan )

Integrated Skin Sensitization Assessment Based on OECD Methods (I): Deriving a Point of Departure for Risk Assessment

Integrated Skin Sensitization Assessment Based on OECD Methods(II): Hazard and Potency by Combining Kinetic Peptide Reactivity and the “2 out of 3” Defined Approach